Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • arussell
    Junior Member
    • Sep 2018
    • 2

    #1

    Adapter enrichment and extension

    Hello,

    I am new to RNA-seq, and am working though the details of how the process works. These are the adapters I am working with, that need to be incorporated into the cDNA.

    PE1: 5' AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT3'

    Index: 5' CAAGCAGAAGACGGCATACGAGATNNNNGTGACTGGAGTTCAGACGTGTGCTCTTCCGAT 3' (NNNN represents barcode nucelotides)

    To the best of my knowledge, the flow cell sequences are:

    p5: 5' AATGATACGGCGACCACC GA 3'
    p7: 5' CAAGCAGAAGACGGCATACGAGAT 3'

    However, I'm not sure if that means those are the sequences that the adapters need to contain, or if those are the binding site sequences and the cDNA needs to contain the complements. Does this mean that my adapterized cDNA sequences will look like scenario 1, 2, or 3?

    1)

    5' PE1 --- cDNA --- Index 3'
    3' PE1(complement) --- cDNA --- Index (complement) 3'

    2)

    5' PE1 --- cDNA --- Index (complement) 3'
    3' PE1 (complement) --- cDNA --- Index 3'

    3)

    5' PE1 --- cDNA --- Index 3'
    3' Index --- cDNA --- PE1'

    **In this case, are the PE1 and Index sequences partially complementary?

    Thank you!

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
51 views
0 reactions
Last Post SEQadmin2  
Working...